Skip to main content

Currently Skimming:

Message from the Co-Chairs
Pages 2-3

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 2...
... The pharmaceutical innovation enterprise faces continued and mounting pressures, strained from all sides by increasing costs, reducing productivity, regulatory and economic uncertainties, and accelerating complexity. In this pivotal time of enormous change and opportunity for pharmaceutical innovation, sustaining and growing the biomedical research enterprise requires a renewed intellectual, business, scientific, and public policy climate in which effective collaboration in research and translation can flourish.
From page 3...
... Presidential initiatives, including a "precision medicine" effort inspired in part by a National Academies report, have been announced and prioritized. The Forum will continue to convene its innovative action collaborative to identify and highlight potentially breakthrough ideas and visionary approaches to the "drug development and translational science enterprise of the future." Individual collaborative participants will provide a discussion paper that will outline a framework and define key terms and activities in the biomedical innovation ecosystem.


This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.